FREE PHENOWEBINARS
Understanding and Applying USP Chapter 621 for Generic Pharmaceutical Applications
Speakers:
Heiko Behr
Senior Business Development Manager, Phenomenex
One webinar, two viewing options
We know you're busy, select a viewing session that works best for you.
Viewing Options
Session 1
Tuesday, February 17, 2026
Los Angeles: 10:00 AM PT | New York: 1:00 PM EST
Mexico City: 12:00 PM CDT
Session 2
Wednesday, February 18, 2026
London: 9:00 AM GMT | Berlin: 10:00 AM CET
Mumbai: 2:30 PM IST
Overview
USP Chapter <621> defines the adjustments that labs may make to their LC methods without having to revalidate. This webinar will cover the guidelines defined in <621> and provide practical examples of how to apply them, enabling scientists to confidently modernize their methods by improving speed and performance without the hassle of revalidation.
Key Learning Points
- Understand how <621> harmonizes multiple Pharmacopeia, including the European and United States, creating new allowable adjustments to monograph methods.
- Identify and apply technical details to Stationary Phase, Mobile Phase and Column Dimension allowable adjustments to improve method performance while maintaining compliance.
- Learn how practical examples of existing Monograph methods, and how utilizing these adjustments improves method performance.
Who Should Attend
- Any laboratory managers, bench chemists, or QA/QC analysts who work with USP monographs in pharmaceutical and nutraceutical.
